SPSIP Block in Breast Surgeries for Postoperative Analgesia

Is Serratus Posterior Superior Intercostal Plane Block Effective in Modified Radical Mastectomy Surgeries?

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT06100419

Acronym

SPSIPB

Enrollment

Registered

2023-10-25

Start date

2023-06-22

Completion date

2023-07-22

Last updated

2023-10-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postmastectomy Pain

Keywords

serratus posterior superior intercostal plane block, regional anaesthesia, postmastectomy pain, interfascial plane blocks

Brief summary

The aim of this clinical study is to demonstrate that pain following breast surgeries can be reduced through the application of serratus posterior superior intercostal plane block (SPSIPB). Seven patients scheduled for breast surgery were included in the study. The primary research question it seeks to address is as follows: • Can SPSIPB be applied to reduce pain following breast surgeries? Participants are expected to provide accurate responses to the researcher's questions for the assessment of postoperative pain.

Detailed description

Postoperative analgesia techniques for breast surgeries encompass options such as Paravertebral Block, Erector Spinae Plane Block, Serratus Anterior Plane Block, and Pectoral Nerve Blocks. Although the Paravertebral Block is considered the gold standard for postmastectomy pain relief, its limited usage is primarily attributed to complications. SPSIPB's potential in thoracic surgeries has been noted, offering a broad sensory block suitable for MRM and axillary lymph node dissection. In this study, the effectiveness of SPSIP block for post-mastectomy pain has been investigated.

Interventions

PROCEDUREserratus posterior superior intercostal plane block

With this newly introduced procedure added to the literature, patients undergoing breast surgeries are expected to experience reduced pain.

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

PREVENTION

Masking

NONE

Intervention model description

case series

Eligibility

Sex/Gender

FEMALE

Healthy volunteers

Yes

Inclusion criteria

* Female patients who will undergo breast surgery

Exclusion criteria

* unstable patients * patients with bleeding disorders * Patients allergic to local anesthetic drugs * Patients who did not agree to participate in the study * Patients with infection at the application site

Design outcomes

Primary

Measure	Time frame	Description
numeric rate scores (NRS)	first 24 hours	The pain levels of patients are indicated with a number between 1 and 10. its means: 0=no pain, 10=worst pain.

Secondary

Measure	Time frame	Description
total tramadol consumption	first 24 hours	The total analgesic quantity that patients will consume for pain reduction.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026